Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	-99.55	4.45	-997.39
Graham Fair Price	42.05	0.05	0.04
PEG	-45.31	0.01	-0.02
Price/Book	-0.44	1.42	1.43
Price/Cash Flow	32.69	1089.10	820.81
Prices/Earnings	-50.22	1.08	2.18
Price/Sales	29122.38	2408.41	8.24
Price/FCF	32.69	1089.10	820.81
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	0.00	1.00	1.00
Operating Margin	58603.25	560.50	0.95
ROA	100.00	0.28	0.14
ROE	0.16	0.33	100.00
ROIC	0.16	0.31	97.82
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	0.05	-0.07	-26.76
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	1.10	1.00	-9.15
EPS QOQ	1.10	1.00	-8.99
FCF QOQ	-0.98	-0.25	74.50
Revenue QOQ	36103.50	-1.00	-100.00
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	0.00	7321.46	100.00
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	0.05	0.05	-0.86
Quick Ratio	1.36	1.80	32.57
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	0.02	0.02	0.44
Cash	< 0.005	< 0.005	-0.09
Capex	0.00	0.00	0.00
Free Cash Flow	< 0.005	< 0.005	-24.63
Revenue	< 0.005	< 0.005	-99.66
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	3.15	3.15	0.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-32.90	0.16	-99.53
Naive Interpretation	Member

06 - Financial Health · Bad

Rating